Spine BioPharma, Inc., a development stage company committed to non-opiate, non-surgical therapies for Degenerative Disc ...

Canaccord analyst Kingsley Crane raised the firm’s price target on CrowdStrike (CRWD) to $420 from $370 and keeps a Buy rating on the shares.

Canaccord raised the firm’s price target on Okta (OKTA) to $100 from $94 and keeps a Hold rating on the shares. The firm said they reported ...

The semi-finals of Manx Hockey Association’s men’s and women’s cup, plate and bowl competitions took place on Saturday, with ...

TTEC (NASDAQ:TTEC – Free Report) had its target price reduced by Canaccord Genuity Group from $4.50 to $3.50 in a research ...

Cardinal Energy Ltd. (TSX: CJ) ("Cardinal" or the "Company") is pleased to announce that it has completed its previously ...

CrowdStrike (NASDAQ:CRWD – Free Report) had its price target boosted by Canaccord Genuity Group from $370.00 to $420.00 in a ...

On Feb. 13, CrowdStrike announced a breakthrough in agentic AI-driven security with the release of Charlotte AI Detection Triage. Charlotte AI operates with customer-defined bounded autonomy and ...

The looming end to Australia’s $40bn hybrid securities market represents a big opportunity for stockbroking veteran Geoff ...

Okta Inc (NASDAQ:OKTA) shares are trading higher Tuesday on the heels of the company's better-than-expected financial results. Multiple analysts also upgraded the stock and raised price targets ...

Find insight on lithium, lumber, the impact of tariffs and more in the latest Market Talks covering Basic Materials.

Q4 2024 Earnings Call Transcript March 3, 2025 Quantum-Si incorporated misses on earnings expectations. Reported EPS is ...